Transpose Platform Management — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Ataraxis AIataraxis.aiin𝕏Dec 2024
New York, US
Jan Witowski(Executive Officer, Director)
BoardKrish Ramadural(Director)Rohan Ganeshananthan(Director)
Level Zero Healthlevelzerohealth.comDec 2024
Level Zero Health develops electrochemical and microfluidic biosensor platforms for point-of-care and continuous diagnostic devices.
BiotechHealthtechMedical DevicesDover, US
Ulviyya Rustamova(Executive Officer, Director)Yiran Jia(Director)
BoardPhilip Kneis(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.